3,5-ジブロモベンゾニトリル

3,5-Dibromobenzonitrile

HCID 2797690

基本情報

CAS
97165-77-0
標準SMILES
N#Cc1cc(Br)cc(Br)c1
InChIKey
QUJGDNCWTBTBQD-UHFFFAOYSA-N
分子式
C7H3Br2N
平均分子量
260.91 g/mol
単同位体質量
258.8632233

名称と識別子

優先名称
3,5-Dibromobenzonitrile
IUPAC
3,5-dibromobenzonitrile
現地名
3,5-ジブロモベンゾニトリル
英語名
3,5-DIBROMOBENZONITRILE
分子式
C7H3Br2N
分子量
260.91

名称と別名

3,5-dibromobenzonitrile97165-77-0DTXSID80383944RefChem:91442DTXCID50334968806-988-7Benzonitrile, 3,5-dibromo-MFCD001787703,5-dibromobenzenecarbonitrileMaybridge1_0077943,5-dibromo-benzonitrileSCHEMBL200313
名称をさらに表示
3,5-ジブロモベンゾニトリル3,5-Dibromobenzonitrile 97%3,5-Dibromobenzonitrile,97%
SCHEMBL7881397HMS563K06SBB055510TD1139AKOS005259306CS-W021811FD64131PS-7363

データベース識別子

CAS
97165-77-0
PubChem CID
2797690
DTXSID
DTXSID80383944
EC Number
806-988-7
Nikkaji
J3.002.927E

物性

構造計算による物性

XLogP
3
極性表面積
23.8 Ų
水素結合供与体数
0
水素結合受容体数
1
回転可能結合数
0
重原子数
10

物理化学的性質

融点
98 °C · 98 °C
沸点
261.2 · 261.2±20.0 °C(Predicted)
比重(密度)
2.06 · 2.06±0.1 g/cm3(Predicted)
貯蔵温度
2 · under inert gas (nitrogen or Argon) at 2-8°C
溶解性
soluble in Methanol
外見
powder to crystal

安全と法規制

GHS分類

GHS Classification · 4 件

Danger

H301 (25%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 3 (25%)

安全データ

ridadr
3276
hs_code
29269090
risk_code
20/21/22-36/37/38
hazard_code
Xi
safety_code
26-36/37/39-36-23-22-4
hazard_class
IRRITANT

化学と産業

応用分野 · 1 件

使用3,5-Dibromobenzonitrile is a chemical compound that can be found at high concentrations in the brain of patients with neurodegenerative diseases. 3,5-Dibromobenzonitrile has been shown to bind to metabotropic glutamate receptor 5 (mGluR5) and activate it; it also binds to glutamate receptors. The uptake of 3,5-dibromobenzonitrile by the body is dependent on its molecular orbital type and the functional groups present. Brain tissue samples from patients with neurodegenerative diseases have shown an increase in the amount of 3,5-dibromobenzonitrile binding to mGluR5. This increased binding may be due to a change in the molecular orbitals or functional groups on mGluR5, as well as an increase in expression of this receptor in diseased brains.

サプライヤー100 社

上海凌富药物研究有限公司+86(21)5895 0110 19945755304 · [email protected]
南通润丰石油化工有限公司66017690 19952660367 · [email protected]
上海策嵘生物科技有限公司[email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]

関連反応

14 件

化合物ノート

読み込み中…